Benzinga | Nov 4, 2020 04:44PM EST

CytoSorbents Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $10.55M Beat $9.51M Estimate

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.09) by 77.78 percent. This is a 90.48 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $10.55 million which beat the analyst consensus estimate of $9.51 million by 10.90 percent. This is a 73.04 percent increase over sales of $6.09 million the same period last year.